Natera, Inc. (NTRA)
410.35
+1.88
(+0.46%)
USD |
NASDAQ |
Oct 02, 16:00
410.01
-0.34
(-0.08%)
After-Hours: 20:00
Natera EPS Diluted (Quarterly) : -0.4674 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4674 |
| March 31, 2026 | -0.6013 |
| December 31, 2025 | 0.3383 |
| September 30, 2025 | -0.6381 |
| June 30, 2025 | -0.7401 |
| March 31, 2025 | -0.4967 |
| December 31, 2024 | -0.4092 |
| September 30, 2024 | -0.2552 |
| June 30, 2024 | -0.305 |
| March 31, 2024 | -0.5595 |
| December 31, 2023 | -0.6541 |
| September 30, 2023 | -0.9467 |
| June 30, 2023 | -0.9746 |
| March 31, 2023 | -1.225 |
| December 31, 2022 | -1.367 |
| September 30, 2022 | -1.252 |
| June 30, 2022 | -1.503 |
| March 31, 2022 | -1.450 |
| December 31, 2021 | -1.483 |
| September 30, 2021 | -1.634 |
| June 30, 2021 | -1.317 |
| March 31, 2021 | -0.7366 |
| December 31, 2020 | -0.8862 |
| September 30, 2020 | -0.7209 |
| June 30, 2020 | -0.7542 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.4518 |
| December 31, 2019 | -0.4599 |
| September 30, 2019 | -0.3284 |
| June 30, 2019 | -0.4751 |
| March 31, 2019 | -0.5426 |
| December 31, 2018 | -0.5129 |
| September 30, 2018 | -0.489 |
| June 30, 2018 | -0.62 |
| March 31, 2018 | -0.6073 |
| December 31, 2017 | -0.90 |
| September 30, 2017 | -0.5214 |
| June 30, 2017 | -0.5475 |
| March 31, 2017 | -0.6508 |
| December 31, 2016 | -0.72 |
| September 30, 2016 | -0.50 |
| June 30, 2016 | -0.4501 |
| March 31, 2016 | -0.17 |
| December 31, 2015 | -0.47 |
| September 30, 2015 | -0.39 |
| June 30, 2015 | -3.58 |
| March 31, 2015 | -0.2004 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | -0.0103 |
| March 31, 2014 | -0.1926 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Guardant Health, Inc. | -0.9042 |
| Myriad Genetics, Inc. | -0.4557 |
| CareDx, Inc. | 2.071 |
| Caris Life Sciences, Inc. | -0.0022 |
| BioRestorative Therapies, Inc. | -2.431 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -66.97M |
| Revenue (Quarterly) | 752.75M |
| Total Expenses (Quarterly) | 819.72M |
| Enterprise Value | 58.08B |
| Gross Profit Margin (Quarterly) | 63.70% |
| Profit Margin (Quarterly) | -8.90% |
| Earnings Yield | -0.33% |
| Normalized Earnings Yield | -0.3287 |